• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Current Drug Shortages O - R

 

 

The majority of information in this section is provided to FDA by manufacturers. Communication between FDA and the public is an essential component of preventing and mitigating drug shortages. To ensure that the information in this section is current, FDA appreciates all information and updates about shortages provided by manufacturers. We post information about shortages as soon as we receive it from the manufacturers.  To report information about shortages or supply issues, manufacturers can send updates to drugshortages@fda.hhs.gov. Healthcare professionals and patients are also encouraged to notify us of shortages at drugshortages@fda.hhs.gov.

*Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012

**Listed by Generic name or Active Ingredient**

A  B  C  D  E  F  G  H  I  K  L  M  N  [O – R]  S  T  U  V  X  Y  Z

Ondansetron (Zofran) Injection

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated

Fresenius Kabi, USA

(Formerly APP Pharmaceuticals, LLC)

1-888-386-1300

4 mg; 2 mL (NDC 63323-0373-02)Available Check wholesalers for inventory.

APP currently has both presentations of Ondansetron available. Please check wholesalers for inventory.

 

Shortage per Manufacturer:
Increased demand

Demand increase for the drug.Reverified 4/8/2014
40 mg; 20 mL (NDC 63323-0374-20)Available Check wholesalers for inventory.

Bedford
Customer Service:
1-800-562-4797

20 mL vial (NDC 55390-0121-01)

 Unavailable

Shortage: Pending Manufacturing Change or Addition.

Availability of products are updated on the Bedford Laboratories website
 

OtherReverified
4/21/2014
Caraco
313-871-8400
2 mL ampules (NDC 62756-0181-01)Caraco temporarily discontinued ondansetron injection Other 
20 mL vials (NDC 62756-0182-01)
Hospira, Inc.
Customer Service:
1-877-946-7747
2 mg/mL; 2 mL vials (NDC 0409-4755-03)

Next delivery April 2014

 

Estimated recovery 2Q 2014

Please check with your wholesaler for available inventory. 

Shortage per manufacturer: Manufacturing delay

Other

Reverified 4/13/2014

2 mg/mL; 20 mL vials (NDC 0409-4759-01)

Next delivery April 2014.
Estimated recovery: 2Q 2014.

West-Ward (formerly Baxter products)

Customer Service:
1-800-631-2174
(Formerly a Baxter Product)  

2 mg/mL, 2 mL vial (NDC 0641-6078-25)

West-Ward has inventory available for both presentations.

West-Ward has accelerated production on this product.  
 

West-Ward has increased production and is anticipating having additional product available for release in the January - February 2014 timeframe.

 

Product will be made available as it is released.

Demand increase for the drug.Revised 1/22/2014

2 mg/mL, 20 mL

Vial (0641-6079-01)

Teva
1-800-545-8800
20 mL vials (NDC 00703-7226-01)

20 mL cannot estimate a release date.

 

2 mL has returned to supply.

 Demand increase for the drug.Reverified
3/26/2014
20 mL vials (NDC 00703-7226-03)
2 mL vials (NDC 00703-7221-04)
GlaxoSmithKline
Customer Service:
1-888-825-5249
Zofran injection, 2 mg/mL,
2 mL vials, packages of 5
(NDC 00173-00442-02)
 DiscontinuedGlaxoSmithKline has the following available:

20 mL vial (NDC 00173-0442-00)

GlaxoSmithKline has discontinued Zofran 2 mL vials
Demand increase for the drug.Reverified
11/4/2013
Zofran 20 mL vial
(NDC 00173-0442-00)
Available
Wockhardt
Customer Service:
1-800-346-6854
 2 mg/mL, 2 mL vials, package of 5 (NDC 64679-0726-01)No estimated release date available. Requirements related to complying with good manufacturing practices

Reverified 4/22/2014

2 mg/mL, 20 mL vials, package of 1 (NDC 64679-0727-01)No estimated release date available 

Mylan Institutional
1-888-258-4199 

 

4 mg/2mL x 25 count
(preservative fee, latex free) NDC 0069-1340-16

Unavailable.

Estimated recovery TBD.

 Demand increase for the drug.

Reverified  4/18/2014

 
40mg/20mL x 1 MDV
(NDC 0069-1340-02)

Unavailable.

Estimated recovery  TBD.

Sagent Pharmaceuticals 1-866-625-1618

 

 

2 mg/mL 2mL vial (NDC 25021-777-02)Available 
 
 
Demand increase of the drug

Reverified
4/14/2014

 
2mg/mL  20mL vial (NDC 25021-782-20)Available

BD Rx Inc.

Customer Service: 1-866-943-8534

4 mg/2 mL (2 mg/mL), single-use Pre-filled syringe (Preservative-Free) NDC 76045-103-20AvailablePlease check with your wholesaler for available inventory.Other

Reverified 4/21/2014
 

AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.)

Customer Service:

(732) 839-9400

4 mg/ 2 mL SDV

(NDC 55150-125-02)

AvailableAll presentations are availableDemand increase for the drug

Reverified

3/18/2014
 

40 mg/ 20 mL MDV

(NDC 55150-126-20)

 

Pancuronium Bromide Injection

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Hospira Inc. Customer Service:
1-877-946-7747
1 mg/mL; 10 mL vial
(NDC 0409-4646-01)

Next delivery May 2014.

Estimated recovery: 2Q 2014.

 

 

Shortage per Manufacturer:
Manufacturing delay
OtherReverified
4/13/2014

 

Papaverine Hydrochloride Injection (Initial Posting Date 12/17/2012)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
American Regent/Luitpold:
1-800-645-1706
30 mg/mL, 2 mL vial (NDC 0517-4002-25)Unavailable - Product on backorder and will be made available as it is released.Shortage per Manufacturer: Manufacturing delayDelay in shipping of the drug.
Demand increase for the drug.
 
Reverifed 4/21/2014 

 

 

Phosphate Injection (Glycophos) (Initial posting - 5/29/2013)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated

Fresenius Kabi, USA

(Formerly APP Pharmaceuticals, LLC)

1-888-386-1300

Glycophos (sodium glycerophosphate) injection, 20 mL vial
(NDC 63323-241-20)  

 

Importation began May 2013. Please check wholesalers for inventory and reference Glycophos.
 
Currently back-ordered. No release data at this time.

 

Fresenius Kabi USA, LLC (FK USA) in conjunction with FDA has initiated temporary importation of Glycophos (sodium glycerophosphate) injection into the US market to address this shortage. Please see the Dear Healthcare Professional Letter (PDF - 443KB) for additional product and supply information.  FK USA is releasing Glycophos to its authorized distributors.
 

Shortage per Manufacturer:
Increase in demand

OtherReverified
4/8/2014
 

 

Pilocarpine HCL Ophthalmic Gel 4% (Pilopine HS) (Initial posting-6/1/12)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Alcon Customer Service: 1-800-862-52664 gm tube: (NDC 0065-0215-35)
 
Unable to estimate a release date

Updates will be provided as further information becomes available.

Shortage per Manufacturer:
Manufacturing delay

 Other

Unable to verify as of 7/19/2013
 

 

Piperacillin and Tazobactam (Zosyn) Injection (Initial Posting Date - 4/2/2014) New!

Company
Product
Availability and Estimated Shortage Duration
Related Information
Shortage Reason
(per New Legislation-FDASIA)*
Date Updated
Apotex Corporation  
1-800-706-5575
2.25 gm/vial (10 Vials) (NDC 60505-0686-4) 
Currently available.
Regulatory delay
3.75 gm/vial (10 Vials) (NDC 60505-0687-4)
4.5 gm/vial (10 Vials) (NDC 60505-0688-4)
40.5 gm/vial (NDC 60505-0773-0)
AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.)

Customer Service:
(732) 839-9400
2.25 g SDV
Cartons of 10 (NDC 55150-119-30)
Available
All presen­tations are available; no supply issues anticipated.
Other
 
3.375 g SDV
Cartons of 10 (NDC 55150-120-30)
4.5 g SDV
Cartons of 10 (NDC 55150-121-50)
Fresenius Kabi, USA     (Formerly APP Pharmaceuticals, LLC)
1-888-386-1300  
2.25 g, single-dose vial (NDC 63323-309-20)
Available. Check wholesalers for inventory.
Available. 
Demand increased for the drug.
Reverified
4/8/2014
 
3.375 g, single-dose vial (NDC 63323-300-30)
4.5 g, single-dose vial (NDC 63323-320-50)
40.5 g, PBP (NDC 63323-304-74)
Hospira, Inc. 
1-877-946-7747
2.25 g Add-Vantage Vial
(NDC 0409-3374-02)
Available
 
Please check with your wholesaler for available inventory.
 
 
Shortage of Manufacturer: Manufacturing delay for Add-Vantage; increased demand for vial.
 
Other. Demand increased for the drug.
Reverified
4/13/2014
 
3.375 g; Add-Vantage Vial
(NDC 0409-3378-13)
TBD
4.5 g; Add-Vantage Vial
(NDC 0409-3379-04)
TBD
2.25 g; Vial
(NDC 0409-3383-02)
Available
 
3.375 g; Vial
(NDC 0409-3385-13
Available
 
4.5 g; Vial
(NDC 0409-3390-04
Available
 
Pfizer Customer Service
1-800-533-4535
Zosyn 2.25g 10's (NDC 0206-8852-16)
Available
 
Delay in shipping of the drug.
Revised
4/11/2014
 
Zosyn 2.25g 10's (Amerinet Choice) (NDC 0206-2100-02)
Available
Zosyn 2.25g 10's (Novaplus) (NDC 0206-2404-02)
Available
Zosyn 2.25g 10's (PremierPro) (NDC 0206-2501-10)
Available
Zosyn 3.375g 10's (NDC 0206-8854-16)
Full recovery estimated September 2014.
Zosyn 3.375g 10's (Amerinet Choice) (NDC 0206-3100-02)
Available
Zosyn 3.375g 10's (Novaplus) (NDC 0206-2405-02)
Full recovery estimated 6/15/14.
Zosyn 3.375g 10's (PremierPro) (NDC 0206-3501-10)
Full recovery estimated 5/15/14.
Zosyn 4.5g 10's (NDC 0206-8855-16)
Full recovery estimated 5/15/14.
Zosyn 4.5g 10's (Amerinet Choice) (NDC 0206-4100-02)
Available
Zosyn 4.5g 10's (Novaplus) (NDC 0206-2408-02)
Available
Zosyn 4.5g 10's (PremierPro) (NDC 0206-4501-10)
Available
Zosyn 40.5g Pharm Bulk 1's (NDC 0206-8859-10)
Available
Zosyn 40.5g Pharm Bulk 1's (Novaplus) (NDC 0206-2416-01)
Available
Sagent Pharmaceuticals
1-866-625-1618
2.25mg 30mL vial, (NDC 25021-164-30)
Available
 
Delay in shipping of the drug.
Demand increase for the drug.
Reverified
4/14/2014
3.375g 30mL vial, (NDC 25021-165-30)
4.5g 48mL vial, (NDC 25021-166-48)
WG Critical Care
1-888-493-0861
 
2.25g (NDC 44567-0801-10)
 
Inventory is available on all codes, and stocked at all wholesalers.
Product is readily available. 
Other
 
3.375g (NDC 44567-0802-10)
 
4.5g (NDC 44567-0803-10)
40.5g (NDC 44567-0804-01)
Sandoz, Inc. Customer Service
1-800-525-8747
4.5g (NDC 00781-3114-95)
Available.  Current product in house short dated.
 
 Other
Revised
4/8/2014
3.75g (NDC 00781-3113-95)
2.25g (NDC 00781-3110-95)

 

Potassium Acetate Injection, USP 2 mEq/mL

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
American Regent/Luitpold:
1-800-645-1706
20 mL vial, package of 25 (NDC 00517-2053-25)Unavailable - No product available for release. No plan to manufacture

American Regent is currently not releasing Potassium Acetate Injection, USP.

Shortage of active ingredientReverified
4/21/2014
 
50 mL vial, package of 25 (NDC 00517-2450-25)
100 mL Pharmacy Bulk Package, package of 25 (NDC 00517-2400-25)

Hospira, Inc.
Customer Service:
1-877-946-7747

Potassium acetate injection, 2 meq/mL,
20 mL vial (NDC 00409-8183-01)

Available

Shortage per manufacturer: AvailableOtherReverified
4/13/2014
50 mL vial (NDC 00409-3294-51)

Available

 

Potassium Chloride Injection (Initial posting - 5/15/2012)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated

 

Fresenius Kabi, USA

(Formerly APP Pharmaceuticals, LLC)

1-888-386-1300

2 mEq/mL, 5 mL vials, (NDC 63323-0965-05)

Available. Check wholesalers for inventory.

Shortage per Manufacturer:
Increased demand

Manufacturing Delay

Demand increase for the drug.

Revised 4/8/2014

2 mEq/mL, 10 mL vials, (NDC 63323-0965-10)

Available. Check wholesalers for inventory.

2 mEq/mL, 15 mL vials, (NDC 63323-0965-15)

Unavailable

2 mEq/mL, 20 mL vials, (NDC 63323-0965-20)

Available. Check wholesalers for inventory.

2 mEq/mL, 30 mL vials, (NDC 63323-0967-30)

Available. Check wholesalers for inventory.

B. Braun Medical Inc.
Customer Service:
1-800-227-2862

2 mEq/mL, 250 mL bulk package (NDC 00264-1940-20)

Available

Shortage Per manufacturer: No shortage

Other

Reverified
2/27/2014

 

Baxter
Customer Service:
1-800-ANA-DRUG
(1-800-262-3784)

10 mEq/100 mL in sterile water (NDC 00338-0709-48)

Available 

 

 

 

 

 

Demand increase for the drug.

 

Reverified 3/17/2014

20 mEq/100 mL in sterile water (NDC 00338-0705-48)

Available 

40 mEq/100 mL in sterile water (NDC 00338-0703-48)

Available 

20 mEq/50 mL in sterile water (NDC 00338-0703-41)

Available

10 mEq/50 mL in sterile water (NDC 00338-0705-41)

Available

20 mEq/1000 mL in lactated ringers and dextrose 5% (NDC 00338-0811-04)

Available

20 mEq/1000 mL in 5% dextrose and 0.9% sodium chloride (NDC 00338-0803-04)

Baxter is experiencing limited supplies and anticipates supplies to recover by March 2014.

20 mEq/1000 mL in 0.9% sodium chloride (NDC 00338-0691-04)

Baxter is experiencing limited supplies and anticipates supplies to recover by April 2014.

 

 

 

40 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00338-0675-04)

Baxter is experiencing limited supplies and anticipates supplies to recover by May 2014.

20 mEq/1000 mL in 5% dextrose (NDC 00338-0683-04)

Baxter is experiencing limited supplies and anticipates supplies to recover by March 2014.

40 mEq/1000 mL in 0.9% sodium chloride (NDC 00338-0695-04)

Baxter is experiencing limited supplies and anticipates supplies to recover by April 2014.

20 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00338-0671-04)

Available

20 mEq/500 mL in 5% dextrose and 0.45% sodium chloride (NDC 00338-0671-03)

Available

 

20 mEq/1000 mL in 0.45% sodium chloride (NDC 00338-0704-34)

Baxter is experiencing limited supplies and anticipates supplies to recover by April 2014.

 

 

 

40 mEq/1000 mL in 5% dextrose and 0.9% sodium chloride (NDC 00338-0807-04)

Available

20 mEq/500 mL in 5% dextrose and 0.2% sodium chloride (NDC 00338-0663-03)

Available

20 mEq/1000 mL in 5% dextrose and 0.2% sodium chloride (NDC 00338-0663-04)

Available

10 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00338-0669-04)

Baxter is experiencing limited supplies and anticipates supplies to recover by March 2014.

Hospira, Inc.
Customer Service:
1-877-946-7747

2 mEq/mL; 250 mL bottle (NDC 0409-1513-02)


 

Available 

Please check with your wholesaler for available inventory. 

 

Shortage per manufacturer: Demand for increase of drug; Available.

Demand increase for the drug/OtherRevised
4/13/2014

2 mEq/mL; 15 mL vial (NDC 0409-6636-01)

Next delivery and estimated recovery TBD

2 mEq/mL; 20 mL vial (NDC 0409-6651-06)

Available

2 mEq/mL; 20 mL vial (NDC 0409-6653-05)

Available 

10 mEq/100 mL (NDC 0409-7074-26)

Available

10 mEq/50 mL (NDC 0409-7075-14)

Available

20 mEq/100 mL,
(NDC 0409-7075-26)

Available

20 mEq/50 mL
(NDC 0409-7077-14)

Available

40 mEq/100 mL
(NDC 0409-7077-26)

Available

40 mEq/1000 mL
(NDC 0409-7116-09)

Next delivery late April 2014.

Estimated recovery April 2014.

20 mEq/1000 mL in 0.9% NaCl
(NDC 0409-7115-09)

Next delivery April 2014

Estimated recovery 2Q 2014

20 mEq/1000 mL in 5% dextrose (NDC 0409-7905-09)

Next delivery 2Q 2014 Estimated recovery 2Q 2014

20 mEq/1000 mL in 5% Dex/Lact Ringers (NDC 0409-7111-09)

Available

10 mEq/500 mL in 5% dex & 0.225% NaCl
(NDC 0409-7901-03)

Next delivery 2Q 2014

Estimated recovery 2Q 2014

10 mEq/ 500 mL in 5% dex 0.45% NaCl
(NDC 0409-7902-03)

Available

20 mEq/1000 mL in 5% dex& 0.225% NaCl
(NDC 0409-7901-09)

Available

20 mEq/1000 mL in
5% dex& 0.45% NaCl
(NDC 0409-7902-09)

Next delivery Mid April 2014
Estimated recovery Late April 2014
 

30 mEq/1000 mL in
5% dex& 0.45% NaCl
(NDC 0409-7903-09)

Available

40 mEq/1000 mL in
5% dex& 0.45% NaCl
(NDC 0409-7904-09)

Available

10 mEq/1000 mL in 5% dex & 0.45% NaCl
(NDC 0409-7993-09)

Available

20 mEq/1000 mL in 5% dex & 0.9% NaCl
(NDC 0409-7107-09)

Available

40 mEq/1000 mL in 5% dex & 0.9% NaCl (NDC 0409-7109-09)

Available

 

Potassium Phosphate Injection   (Also See Phosphate Injection)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated

Fresenius Kabi, USA

(Formerly APP Pharmaceuticals, LLC)

1-888-386-1300

15 mMol/mL, 5 mL SDV (NDC 63323-0086-05)Currently available.  Check wholesalers for inventory. Check wholesalers for inventory.Demand increase for the drug.Revised
4/8/2014
 
45 mMol/mL, 15 mL SDV (NDC 63323-0086-15)Backordered. Next release anticipated May 2014.
150 mMol/mL, 50 mL SDV (NDC 63323-0086-50)Currently available.  Check wholesalers for inventory.
Hospira Inc.
(1-877-946-7747)
3 mMol/mL, 15 mL vial (NDC 0409-7295-01)

Available

 Demand increase for the drug

Revised
4/13/2014

American Regent/Luitpold
1-800-645-1706
3 mMol/mL, 5 mL vial, package of 25 (NDC 00517-2305-25)

Unavailable - No product available for release. No plan to manufacture. 

American Regent/Luitpold is not releasing the 5 mL, 15 mL or 50 mL vials.  

 
Shortage of active ingredient

Reverified 
4/21/2014

3 mMol/mL, 15 mL vial, package of 25 (NDC 00517-2315-25)

Unavailable - No product available for release. No plan to manufacture. 

3 mMol/mL, 50 mL vial, package of 25 (NDC 00517-2350-25)

Unavailable - No product available for release. No plan to manufacture. 

 

Procainamide HCL Injection

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Hospira Inc. Customer Service:
1-877-946-7747

100 mg/mL; 10 mL vial

(NDC 0409-1902-01)

 

Next delivery June 2014. 

 

Estimated recovery 2Q 2014.

Please check with your wholesaler for available inventory. 

Shortage per Manufacturer: Manufacturing delay/Available

OtherReverified
4/13/2014

500 mg/mL; 2 mL vial

(NDC 0409-1903-01)

Available

 

Prochlorperazine Injection (1/30/2012)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Bedford Customer Service
1-800-562-4797
5 mg/mL, 2mL vial, 10 count (NDC 55390-0077-10)
 
2 mL is AVAILABLE in limited quantities. 

 

Demand increase for the drug.

Reverified
4/21/2014
 

Heritage Pharmaceuticals Inc.
Customer Service
 1-866-901-3784
5 mg/mL: 2mL vial, package of 10 (NDC 23155-294-42)Available from January 2014New launchOtherNew
1/15/2014

 

 Reserpine Tablets (Initial post date-4/17/2013)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated

Sandoz, Inc. Customer Service
1-800-525-8747

0.25 mg  100s
(NDC 0185-0134-01)
Next available supply October 2014Active Pharmaceutical Ingredient and Raw Material changes Required. Changes currently in process.OtherReverified 4/8/2014
0.25 mg   1000s
(NDC 0185-0134-10)
0.1 mg   100s (NDC 0185-0032-01)
0.1 mg   1000s
(NDC 0185-0032-10)

 

Rifampin for Injection (Initial posting-3/22/2013)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated

Mylan Instututional
1-888-258-4199 

600 mg vial (NDC 0069-0112-01)Unavailable.
Estimated recovery: June 2014
 

 

Demand increase for the drug

Reverified
4/18/2014
 

 

Sanofi
1-609-627-8500

600 mg vial (NDC 00068-0597-01)Available  

Reverified 3/25/2014

Akorn:
1-800-932-5676
600 mg vial (NDC 17478-0151-42)

Unavailable

 

Seeking re-introduction during 4Q 2013

Please check with your wholesaler for available inventory

Shortage per manufacturer: manufacturing delay

Demand increase for the drug.

Reverified
9/13/2013
 

Bedford

Customer Service:
1-800-562-4797

600 mg vial (NDC 55390-0123-01)

Unavailable

Shortage: Pending Manufacturing Change or Addition. Availability of products is updated on the Bedford Laboratories website.


 

Other

Reverified
4/21/2014

 

back to top of page

Current Drug Shortages Index